Konstantinos Stavroulakis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Konstantinos Stavroulakis has a total of 458 co-authors. Here are the top co-authors by number of shared publications:
Giovanni Torsello
21 shared publicationsTheodosios Bisdas
3rd Department of Vascular Surgery, Athens Medical Center, Athens, Greece
21 shared publications- Giovanni Torsello
Department of Cardiac, Thoracic and Vascular Surgery, University Medical Centre Göttingen, Germany
18 shared publications Nikolaos Tsilimparis
Department of vascular surgery, University Hospital, LMU Munich, Germany
15 shared publications- Nikolaos Tsilimparis
Department of Vascular Surgery, University Hospital LMU Munich, Munich, Germany
13 shared publications - Angeliki Argyriou
Department of Vascular Surgery, Marien Hospital Herne, Herne, Germany
12 shared publications
Latest Publications
- 28 October 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
Beyond Financial Conflicts of Interest in Vascular Practice
- 28 October 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
Beyond Financial Conflicts of Interest in Vascular Practice
- 19 June 2026
- Published by Hogrefe Publishing Group in Vasa
Long-term outcomes of covered versus bare metal stents in the reconstruction of the aortic bifurcation
Summary: Background: To report long-term outcomes following stenting for aortoiliac occlusive disease, focusing on covered stents (CS) versus bare metal stents (BMS) in a real-world, multicentre European cohort. Design: Multicentre retrospective cohort study. Patients and methods: Prospectively maintained data from nine European vascular centres (2012–2020) were analysed. Two cohorts were evaluated: aortic-only stenting and aortoiliac stenting (stratified as CS/CS, CS/BMS, BMS/CS, and BMS/BMS). Primary outcomes were target lesion revascularisation (TLR), major amputation, and mortality, with median follow-up of 75 months. Cox regression and propensity score matching were performed to adjust for baseline anatomical and procedural differences between stent types. Results: A total of 201 patients were included (50% male, mean age 65 years, 34% with chronic limb-threatening ischaemia). In the aortic-only subgroup (n = 46), outcomes were comparable between CS and BMS. Among aortoiliac reconstructions (n = 155), patients treated with CS/CS had greater anatomical complexity, including higher prevalence of iliac chronic total occlusions, longer lesions, and heavier calcification. Independent predictors of TLR included iliac chronic total occlusion, subintimal aortic recanalization, and concomitant common femoral endarterectomy. After propensity score adjustment, there remained no significant difference in TLR (28/155), major amputation (4/155), or mortality (30/155) between CS/CS and BMS/BMS groups. Conclusions: CS was preferentially employed in more complex aortoiliac occlusive disease and achieved outcomes equivalent to BMS after adjustment for lesion severity using propensity score methods. These findings reinforce that operator selection patterns and lesion complexity, rather than stent type alone, influence the clinical outcomes, underscoring the need for individualised stent selection strategies in advanced aortoiliac disease.
- 19 June 2026
- Published by Hogrefe Publishing Group in Vasa
Long-term outcomes of covered versus bare metal stents in the reconstruction of the aortic bifurcation
Summary: Background: To report long-term outcomes following stenting for aortoiliac occlusive disease, focusing on covered stents (CS) versus bare metal stents (BMS) in a real-world, multicentre European cohort. Design: Multicentre retrospective cohort study. Patients and methods: Prospectively maintained data from nine European vascular centres (2012–2020) were analysed. Two cohorts were evaluated: aortic-only stenting and aortoiliac stenting (stratified as CS/CS, CS/BMS, BMS/CS, and BMS/BMS). Primary outcomes were target lesion revascularisation (TLR), major amputation, and mortality, with median follow-up of 75 months. Cox regression and propensity score matching were performed to adjust for baseline anatomical and procedural differences between stent types. Results: A total of 201 patients were included (50% male, mean age 65 years, 34% with chronic limb-threatening ischaemia). In the aortic-only subgroup (n = 46), outcomes were comparable between CS and BMS. Among aortoiliac reconstructions (n = 155), patients treated with CS/CS had greater anatomical complexity, including higher prevalence of iliac chronic total occlusions, longer lesions, and heavier calcification. Independent predictors of TLR included iliac chronic total occlusion, subintimal aortic recanalization, and concomitant common femoral endarterectomy. After propensity score adjustment, there remained no significant difference in TLR (28/155), major amputation (4/155), or mortality (30/155) between CS/CS and BMS/BMS groups. Conclusions: CS was preferentially employed in more complex aortoiliac occlusive disease and achieved outcomes equivalent to BMS after adjustment for lesion severity using propensity score methods. These findings reinforce that operator selection patterns and lesion complexity, rather than stent type alone, influence the clinical outcomes, underscoring the need for individualised stent selection strategies in advanced aortoiliac disease.
- 1 June 2026
- Published by Hogrefe Publishing Group in Vasa
- Vol. 55 (4) , 259-268
Recoil, dissection, and restenosis in Below-The-Knee (BTK) arteries following standard balloon angioplasty
Summary: Peripheral artery disease (PAD) is a growing health problem, with symptoms ranging from intermittent claudication to chronic limb-threatening ischemia (CLTI). Balloon angioplasty in below-the-knee (BTK) PAD lesions is the mainstay treatment procedure but still a challenging one, given the heterogeneity in the patient population, multivessel and multilevel involvement, small-vessel size, long lesions (up to 40 cm), calcium burden, and lower flow rates with or without impaired runoff. The technical success of balloon angioplasty is often subverted by flow-limiting dissections, recoil with early restenosis. This review will explore current guidelines, revascularization anatomical planning, interventional approaches, and possible solutions to avoid the feared dissection, recoil and restenosis that our patients currently face.
- 1 June 2026
- Published by Hogrefe Publishing Group in Vasa
- Vol. 55 (4) , 259-268
Recoil, dissection, and restenosis in Below-The-Knee (BTK) arteries following standard balloon angioplasty
Summary: Peripheral artery disease (PAD) is a growing health problem, with symptoms ranging from intermittent claudication to chronic limb-threatening ischemia (CLTI). Balloon angioplasty in below-the-knee (BTK) PAD lesions is the mainstay treatment procedure but still a challenging one, given the heterogeneity in the patient population, multivessel and multilevel involvement, small-vessel size, long lesions (up to 40 cm), calcium burden, and lower flow rates with or without impaired runoff. The technical success of balloon angioplasty is often subverted by flow-limiting dissections, recoil with early restenosis. This review will explore current guidelines, revascularization anatomical planning, interventional approaches, and possible solutions to avoid the feared dissection, recoil and restenosis that our patients currently face.
- 6 March 2026
- Published by Hogrefe Publishing Group in Vasa
Comparative outcomes and costs of AngioJet™ versus lysis-first strategy in acute limb ischemia treatment
Summary: Background: This study compared outcomes of a pharmacomechanical thrombectomy (PMT)-first strategy using the AngioJet™ system versus catheter-directed thrombolysis (CDT) in the treatment of acute limb ischemia (ALI). Patients and methods: We retrospectively analysed 100 patients with ALI (Rutherford I–IIb) treated between January 2016 and September 2024. Patients received either primary PMT with AngioJet™ (n = 57) or primary CDT (n = 43). The primary endpoint was amputation-free survival (AFS). Secondary endpoints included technical success, major amputation, mortality, reintervention, and in-hospital cost. Cox regression was used for time-to-event data; cost analysis employed a generalised linear model. Results: Technical success was higher with AngioJet™ (96.5% vs. 65.1%, p < .001). Median thrombolysis duration (1 h vs. 24 h, p < .001), hospital stay (6 vs. 11 days, p = .002), and ICU stay (1 vs. 2 days, p < .001) were significantly reduced. Median inpatient costs were lower in the AngioJet™ group (€9,298 vs. €13,790; exp(B) 1.308, 95% CI 1.07–1.6, p = .009). No significant differences were observed in 30-day mortality, major amputation, bleeding, or acute kidney injury. At 12-months AFS was similar (57.9% vs. 51.2%, p = .55). While major amputation was less frequent after AngioJet™ (5.4% vs. 18.6%, p = .05), this was not significant in multivariate analysis. CDT was independently associated with higher reintervention rates (HR 2.57, p = .03). Conclusions: In this cohort, a primary AngioJet™ strategy was associated with advantages in technical outcomes, hospitalisation, costs, and reinterventions, while amputation-free survival remained comparable to primary CDT. These findings support its use as an effective endovascular option in selected ALI patients.
- 6 March 2026
- Published by Hogrefe Publishing Group in Vasa
Comparative outcomes and costs of AngioJet™ versus lysis-first strategy in acute limb ischemia treatment
Summary: Background: This study compared outcomes of a pharmacomechanical thrombectomy (PMT)-first strategy using the AngioJet™ system versus catheter-directed thrombolysis (CDT) in the treatment of acute limb ischemia (ALI). Patients and methods: We retrospectively analysed 100 patients with ALI (Rutherford I–IIb) treated between January 2016 and September 2024. Patients received either primary PMT with AngioJet™ (n = 57) or primary CDT (n = 43). The primary endpoint was amputation-free survival (AFS). Secondary endpoints included technical success, major amputation, mortality, reintervention, and in-hospital cost. Cox regression was used for time-to-event data; cost analysis employed a generalised linear model. Results: Technical success was higher with AngioJet™ (96.5% vs. 65.1%, p < .001). Median thrombolysis duration (1 h vs. 24 h, p < .001), hospital stay (6 vs. 11 days, p = .002), and ICU stay (1 vs. 2 days, p < .001) were significantly reduced. Median inpatient costs were lower in the AngioJet™ group (€9,298 vs. €13,790; exp(B) 1.308, 95% CI 1.07–1.6, p = .009). No significant differences were observed in 30-day mortality, major amputation, bleeding, or acute kidney injury. At 12-months AFS was similar (57.9% vs. 51.2%, p = .55). While major amputation was less frequent after AngioJet™ (5.4% vs. 18.6%, p = .05), this was not significant in multivariate analysis. CDT was independently associated with higher reintervention rates (HR 2.57, p = .03). Conclusions: In this cohort, a primary AngioJet™ strategy was associated with advantages in technical outcomes, hospitalisation, costs, and reinterventions, while amputation-free survival remained comparable to primary CDT. These findings support its use as an effective endovascular option in selected ALI patients.
- 4 March 2026
- Published by Hogrefe Publishing Group in Vasa
Clinical outcomes and cost analysis of plug-based versus suture-based vascular closure devices for percutaneous large bore aortic procedures
Summary: Background: To compare the clinical outcomes and the costs of the plug-based- versus suture-based vascular closure device following large-bore percutaneous aortic procedures. Materials and methods: This single-centre retrospective analysis included 68 consecutive patients undergoing endovascular aortic procedures between January 2024 and May 2025. Femoral artery closure was achieved using either the MANTA (Teleflex, Wayne, Pennsylvania) or Perclose ProStyle (Abbott Vascular, Abbott Park, Il) vascular closure device. Procedural details, anatomical parameters, and access-site outcomes were analysed. The primary endpoint was technical success. Secondary endpoints included bleeding, vessel occlusion, pseudoaneurysm, access-site thrombosis, surgical conversion, and device-related cost per access site. Results: Sixty-eight patients with 111 femoral access sites (71 MANTA, 40 Perclose ProStyle) were included. No differences were observed between groups regarding aortic pathology, access vessel diameter, or calcification severity. Technical success was high in both groups (97.5% Perclose ProStyle vs. 93.0% MANTA; p = .312). Access-site complications occurred more frequently in the MANTA group, including all pseudoaneurysms (2.8%) and most surgical conversions (7.0% vs. 2.5%), although differences were not statistically significant. No access-site thrombosis was observed. Mean device-related cost per access site was significantly higher for MANTA than for Perclose ProStyle (€466 vs. €290; p = .001). Conclusions: Both MANTA and Perclose ProStyle devices achieved high rates of successful large-bore femoral closure. However, the suture-based ProGlide system was associated with lower cost and fewer access-site complications. Given the retrospective design and operator-driven device selection, these findings should be interpreted with caution.
- 4 March 2026
- Published by Hogrefe Publishing Group in Vasa
Clinical outcomes and cost analysis of plug-based versus suture-based vascular closure devices for percutaneous large bore aortic procedures
Summary: Background: To compare the clinical outcomes and the costs of the plug-based- versus suture-based vascular closure device following large-bore percutaneous aortic procedures. Materials and methods: This single-centre retrospective analysis included 68 consecutive patients undergoing endovascular aortic procedures between January 2024 and May 2025. Femoral artery closure was achieved using either the MANTA (Teleflex, Wayne, Pennsylvania) or Perclose ProStyle (Abbott Vascular, Abbott Park, Il) vascular closure device. Procedural details, anatomical parameters, and access-site outcomes were analysed. The primary endpoint was technical success. Secondary endpoints included bleeding, vessel occlusion, pseudoaneurysm, access-site thrombosis, surgical conversion, and device-related cost per access site. Results: Sixty-eight patients with 111 femoral access sites (71 MANTA, 40 Perclose ProStyle) were included. No differences were observed between groups regarding aortic pathology, access vessel diameter, or calcification severity. Technical success was high in both groups (97.5% Perclose ProStyle vs. 93.0% MANTA; p = .312). Access-site complications occurred more frequently in the MANTA group, including all pseudoaneurysms (2.8%) and most surgical conversions (7.0% vs. 2.5%), although differences were not statistically significant. No access-site thrombosis was observed. Mean device-related cost per access site was significantly higher for MANTA than for Perclose ProStyle (€466 vs. €290; p = .001). Conclusions: Both MANTA and Perclose ProStyle devices achieved high rates of successful large-bore femoral closure. However, the suture-based ProGlide system was associated with lower cost and fewer access-site complications. Given the retrospective design and operator-driven device selection, these findings should be interpreted with caution.
- Top Cited PapersOpen Access
- 1 March 2026
- Published by Hogrefe Publishing Group in Vasa
- Vol. 55 (2) , 144-151
Intravascular Lithotripsy-Enhanced Treatment of Paravisceral Coral Reef Aorta
Summary: Background: Coral reef aorta (CRA) is a rare and therapeutically challenging condition characterized by heavily calcified paravisceral aortic stenosis, leading to severe clinical manifestations. Open surgery is associated with substantial perioperative morbidity and mortality, while standard endovascular approaches often face technical limitations. This multicentre study aimed to evaluate the feasibility and safety of intravascular lithotripsy (IVL) combined with aortic and/or reno-visceral vessel (RVV) stenting for the treatment of paravisceral CRA. Patients and methods: Patients with paravisceral CRA treated with IVL between 2021 and 2025 across six vascular centres were retrospectively analysed. The primary endpoint was technical success. Secondary endpoints included IVL-related complications, perioperative mortality, freedom from reintervention, clinical improvement, and aortic lumen gain at the site of maximum stenosis. Results: A total of 16 patients were included. Presenting symptoms were claudication (n=15), renal failure (n=9), mesenteric ischemia (n=4), and cardiac failure (n=2). IVL alone was performed in 3 patients (18.8%), while 13 patients (81.2%) underwent adjunctive aortic and/or RVV stenting. Technical success was achieved in all cases. There were no IVL-related complications or perioperative deaths. All patients demonstrated clinical improvement and significant aortic lumen gain. During a median follow-up of 5 (1–11.5) months, two elective reinterventions were required. No patients were lost to follow-up. Conclusions: In our cohort, IVL combined with aortic and/or RVV stenting appeared to be a feasible and safe endovascular strategy for the management of paravisceral CRA. The approach offers high technical success with low perioperative morbidity, mortality, and reintervention rates.
- 1 March 2026
- Published by Hogrefe Publishing Group in Vasa
- Vol. 55 (2) , 144-151
Top Cited PapersOpen AccessIntravascular Lithotripsy-Enhanced Treatment of Paravisceral Coral Reef Aorta
Summary: Background: Coral reef aorta (CRA) is a rare and therapeutically challenging condition characterized by heavily calcified paravisceral aortic stenosis, leading to severe clinical manifestations. Open surgery is associated with substantial perioperative morbidity and mortality, while standard endovascular approaches often face technical limitations. This multicentre study aimed to evaluate the feasibility and safety of intravascular lithotripsy (IVL) combined with aortic and/or reno-visceral vessel (RVV) stenting for the treatment of paravisceral CRA. Patients and methods: Patients with paravisceral CRA treated with IVL between 2021 and 2025 across six vascular centres were retrospectively analysed. The primary endpoint was technical success. Secondary endpoints included IVL-related complications, perioperative mortality, freedom from reintervention, clinical improvement, and aortic lumen gain at the site of maximum stenosis. Results: A total of 16 patients were included. Presenting symptoms were claudication (n=15), renal failure (n=9), mesenteric ischemia (n=4), and cardiac failure (n=2). IVL alone was performed in 3 patients (18.8%), while 13 patients (81.2%) underwent adjunctive aortic and/or RVV stenting. Technical success was achieved in all cases. There were no IVL-related complications or perioperative deaths. All patients demonstrated clinical improvement and significant aortic lumen gain. During a median follow-up of 5 (1–11.5) months, two elective reinterventions were required. No patients were lost to follow-up. Conclusions: In our cohort, IVL combined with aortic and/or RVV stenting appeared to be a feasible and safe endovascular strategy for the management of paravisceral CRA. The approach offers high technical success with low perioperative morbidity, mortality, and reintervention rates.
- Open Access
- 21 January 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 72 (3) , 523-530
Outcomes following Revascularisation for Acute Lower Limb Ischaemia Using Contemporary Endovascular, Hybrid, or Open Surgical Techniques in a Multicentre, Retrospective Cohort: The Acute Lower Limb Ischaemia Vascular Outcomes Evaluation (ALIVE) Registry
- 21 January 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 72 (3) , 523-530
Open AccessOutcomes following Revascularisation for Acute Lower Limb Ischaemia Using Contemporary Endovascular, Hybrid, or Open Surgical Techniques in a Multicentre, Retrospective Cohort: The Acute Lower Limb Ischaemia Vascular Outcomes Evaluation (ALIVE) Registry
- 2 January 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 72 (5) , 772-773
Acute Embolic Mesenteric Ischaemia: Closing the Evidence Gap One Cohort at a Time
- 2 January 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 72 (5) , 772-773
Acute Embolic Mesenteric Ischaemia: Closing the Evidence Gap One Cohort at a Time
- 1 January 2026
- Published by Hogrefe Publishing Group in Vasa
- Vol. 55 (1) , 62-66
Retrograde direct stent puncture for femoropopliteal lesion crossing is safe and effective – results from a multicenter German registry
Summary: Background: To evaluate the safety and efficacy of direct retrograde stent punctures for crossing of chronic total occlusions in patients with symptomatic peripheral arterial disease. Methods: A retrospective registry of consecutive patients treated with retrograde recanalization techniques in five high-volume German centers was performed. Patient cases with attempted retrograde after failed antegrade revascularization were studied. Primary endpoint was technical success. Secondary endpoints were access vessel complications, need for bail-out procedures and major or minor amputation. Results: Of the 1516 retrograde punctures recorded in the registry, 63 (4.2%) were direct stent punctures. Superficial femoral artery stents were punctured in 88.9% (56/63) of the cases, tibial artery stents in 6 patients (9.5%) and a stent in an occluded femoropopliteal bypass in one case (1.6%). Mean lesion length was 322±125 mm. Stent puncture was successful in 62 cases (98.4%) and the procedural success rate was 96.8% (61/63) with one technical failure despite successful puncture. A sheathless approach was performed in 79.4% (50/63) of cases. Drug-coated balloon angioplasty was applied in 63.5% (40/63) and new stenting (bare-metal or drug-eluting) in 55.6% (35/63) of lesions. One minor and no major amputations were recorded in the first 30 days after the procedure. A sheathless retrograde approach was associated with significantly higher procedural technical success (p = .04). Conclusion: Retrograde femoral or tibial direct stent puncture seems to be safe and effective for the recanalization of chronic total occlusions of the femoropopliteal segment in cases where antegrade recanalization is deemed unsuccessful.
- 1 January 2026
- Published by Hogrefe Publishing Group in Vasa
- Vol. 55 (1) , 62-66
Retrograde direct stent puncture for femoropopliteal lesion crossing is safe and effective – results from a multicenter German registry
Summary: Background: To evaluate the safety and efficacy of direct retrograde stent punctures for crossing of chronic total occlusions in patients with symptomatic peripheral arterial disease. Methods: A retrospective registry of consecutive patients treated with retrograde recanalization techniques in five high-volume German centers was performed. Patient cases with attempted retrograde after failed antegrade revascularization were studied. Primary endpoint was technical success. Secondary endpoints were access vessel complications, need for bail-out procedures and major or minor amputation. Results: Of the 1516 retrograde punctures recorded in the registry, 63 (4.2%) were direct stent punctures. Superficial femoral artery stents were punctured in 88.9% (56/63) of the cases, tibial artery stents in 6 patients (9.5%) and a stent in an occluded femoropopliteal bypass in one case (1.6%). Mean lesion length was 322±125 mm. Stent puncture was successful in 62 cases (98.4%) and the procedural success rate was 96.8% (61/63) with one technical failure despite successful puncture. A sheathless approach was performed in 79.4% (50/63) of cases. Drug-coated balloon angioplasty was applied in 63.5% (40/63) and new stenting (bare-metal or drug-eluting) in 55.6% (35/63) of lesions. One minor and no major amputations were recorded in the first 30 days after the procedure. A sheathless retrograde approach was associated with significantly higher procedural technical success (p = .04). Conclusion: Retrograde femoral or tibial direct stent puncture seems to be safe and effective for the recanalization of chronic total occlusions of the femoropopliteal segment in cases where antegrade recanalization is deemed unsuccessful.